Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...
KYW Radio Philadelphia on MSN18h
Medical Report: What does the ban on red dye No. 3 mean?Do you still have candy hearts from Valentine’s Day that say “I love you”? Odds are, red dye No. 3 was used in the ...
Glenmark Pharmaceuticals and FDC Ltd are recalling some products in the US market. Glenmark is recalling certain strengths of ...
MELBOURNE, Australia, Feb. 17, 2025 /PRNewswire/ — Navi Medical Technologies, a medical device company focused on pediatric healthcare innovation, proudly announces that its Neonav® ECG Tip Location ...
Mesoblast's high-risk programs drive inflated valuation. Find out why MESO stock remains a "sell" as execution risks outweigh ...
Cybersecurity company SailPoint opened for trading on Thursday, returning to the markets more than two years after it went private.Maximize ...
Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback